Trial Profile
Study of PCV13 vaccine in infants (aged <1 year) with invasive pnuemococcal disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Oct 2018
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Adverse reactions
- 12 Oct 2018 New trial record
- 03 Oct 2018 Results published in the Clinical Infectious Diseases